Bulacan State University

COLLEGE OF NURSING
City of Malolos, Bulacan

DRUG STUDY
Patient’s Initial: ___________
L.M. Age: ____36____ F
Gender: ________ 11/22/2019
Date Handled: _________________
NSD
Medical Diagnosis: _______________________________ Chief Complaint:Pain related to episiotomy wound Clinical Area: __________________
_________________________ OB WARD (BMC)

DRUG DATA CLASSIFICATION MECHANISM OF INDICATIONS CONTRAINDICATIONS ADVERSE EFFECT NURSING

ACTION RESPONSIBILITIES
Generic name: Therapeutic: Replaces calcium General: Precaution: CNS: tingling Before:
calcium acetate Calcium and maintains  Hypocalcem  Contraindicat sensations, sense of  Tell
supplements calcium level ia ed in cancer oppression or heat patient to
Trade name: Adults: 7-14 mEq patients with waves with I.V. use, take oral
Calphron, elemental calcium I.V. bone syncope with rapid calcium 1
Phoslyra Pregnancy may give as a 10% metastases I.V. use. to ½
Category Risk: calcium chloride and in those CV: bradycardia, hours
Patient’s dose: Category C solution. with arrhythmias, cardiac after
500mg O.D Children: 0.136 to 0.252 ventricular arrest with rapid I.V. meals if
elemental calcium/kg fibrillation, use, mild drop in BP, GI upset
Route: I.V. hypercalcemi vasodilation occurs.
P.O. a, GI: constipation,  Tell
 Adjunctive hypophosph irritation, chalky patient to
treatment of atemia, or taste, hemorrhage, take oral
magnesium renal calculi. nausea, vomiting, calcium
intoxication  Dialyzable thirst, abdominal with a full
Adults: Initially, 7 mEq drug: Yes pain. glass of
I.V. Base subsequent  Overdose: GU: polyuria, renal water.
doses on patient’s Hypercalcem calculi
response. ia, confusion, Metabolic: During:
delirium, hypercalcemia  Warn
 During stupor, Skin: local patient
exchange coma. reactions, including not to eat
transfusion burning necrosis, rhubarb,
Adults: 1.35 mEq I.V. tissue sloughing, spinach,
after each 100 mL cellulitis, soft-tissue bran and
citrated blood whole
Neonates: 0.45 mEq calcification with I.M. grain
I.V. after each 100 mL use. cereals,
citrated blood. or dairy
products
 Hyperphoph in meal
atemia before
Adults: Initially, 2 taking
capsules or tablets or calcium;
10 mL oral solution these
calcium P.O. t.id. with may
meals. Titrate dose interfere
every 2-3 weeks until an with
acceptable serum calcium
phosphorus level is absorptio
reached; watch for n.
hypercalcemia. Most
dialysis patients need 3- After:
4 capsules or tablets or  Tell
15-20 mL oral solution patient to
with each meal. report
anorexia,
 Dietary nausea,
Supplement vomiting,
Adults: 500 mg to 2g constipati
P.O. daily on,
abdomin
 Hyperkalemi al pain,
a with dry
secondary mouth,
cardiac thirst, or
toxicity polyuria.
Adults: 2.25 to 14 mEq  Inform
I.V. Repeat dose after patient
1-2 minutes, if needed. that
some
products
may
contain
phenylala
nine and
tartrazine